ThinkGP
Events by this organizer
august
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only
Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. Timely diagnosis and appropriate pharmacological management are essential to reduce osteoporotic fracture rates. However, fractures are often not linked to osteoporosis, or are seen as unimportant. The disease therefore remains underdiagnosed and undertreated in Australian General Practice.
This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management.
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only
Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. Therapeutic inertia (delays in advancing therapy when appropriate) can increase patients’ risk of diabetic complications, as they may remain above target HbA1c for many years. Delays in the initiation, titration and intensification of insulin are particularly prevalent globally.
This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
september
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only
Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. Timely diagnosis and appropriate pharmacological management are essential to reduce osteoporotic fracture rates. However, fractures are often not linked to osteoporosis, or are seen as unimportant. The disease therefore remains underdiagnosed and undertreated in Australian General Practice.
This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management.
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only
Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. Therapeutic inertia (delays in advancing therapy when appropriate) can increase patients’ risk of diabetic complications, as they may remain above target HbA1c for many years. Delays in the initiation, titration and intensification of insulin are particularly prevalent globally.
This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
october
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only
Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. Timely diagnosis and appropriate pharmacological management are essential to reduce osteoporotic fracture rates. However, fractures are often not linked to osteoporosis, or are seen as unimportant. The disease therefore remains underdiagnosed and undertreated in Australian General Practice.
This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management.
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only
Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. Therapeutic inertia (delays in advancing therapy when appropriate) can increase patients’ risk of diabetic complications, as they may remain above target HbA1c for many years. Delays in the initiation, titration and intensification of insulin are particularly prevalent globally.
This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
november
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only
Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. Timely diagnosis and appropriate pharmacological management are essential to reduce osteoporotic fracture rates. However, fractures are often not linked to osteoporosis, or are seen as unimportant. The disease therefore remains underdiagnosed and undertreated in Australian General Practice.
This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management.
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only
Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. Therapeutic inertia (delays in advancing therapy when appropriate) can increase patients’ risk of diabetic complications, as they may remain above target HbA1c for many years. Delays in the initiation, titration and intensification of insulin are particularly prevalent globally.
This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
december
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 7 hours | GPs only
Overview: By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. Timely diagnosis and appropriate pharmacological management are essential to reduce osteoporotic fracture rates. However, fractures are often not linked to osteoporosis, or are seen as unimportant. The disease therefore remains underdiagnosed and undertreated in Australian General Practice.
This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management.
Event Details
Details: Clinical audit | RACGP: 40 points | ACRRM: 6 hours | GPs only
Overview: Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. Therapeutic inertia (delays in advancing therapy when appropriate) can increase patients’ risk of diabetic complications, as they may remain above target HbA1c for many years. Delays in the initiation, titration and intensification of insulin are particularly prevalent globally.
This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Time
Year Around Event (2022)
Location
Online
Organizer
ThinkGP